Why does hydroxychloroquine need eye exams?

Hydroxychloroquine is a widely prescribed medication used to manage several autoimmune and inflammatory conditions, including lupus and rheumatoid arthritis. It can help reduce inflammation, control disease symptoms, and prevent certain complications. Although it offers important health benefits, long-term use requires careful monitoring. One of the most important safety measures is having regular eye examinations.  The reason hydroxychloroquine requires eye exams is that it can sometimes cause damage to the retina, the light-sensitive tissue located at the back of the eye. This condition is known as hydroxychloroquine retinopathy. It may develop gradually, often without noticeable symptoms during its early stages. If the damage becomes advanced, it can lead to permanent changes in vision.

Regular eye examinations help identify early signs of retinal damage before a person notices changes in everyday activities. Understanding why these examinations matter, when they should be performed, and what tests are involved can help patients use their medication more safely. This guide explains the connection between the medication and eye health, the possible risks, and the steps patients can take to protect their vision.

Hydroxychloroquine and Its Effects on Eye Health

Hydroxychloroquine is an antimalarial medication that is also commonly used to treat autoimmune diseases. It works by modifying certain immune system activities, helping reduce inflammation and prevent the immune system from attacking healthy tissues.

Doctors may prescribe it for conditions such as:

• Systemic lupus erythematosus.

• Rheumatoid arthritis.

• Certain inflammatory skin conditions.

• Some other autoimmune and inflammatory disorders.

For many patients, treatment provides long-term benefits. However, like other medications, it can have side effects. One particularly important concern is its potential effect on the retina.

The retina processes light and sends visual information to the brain through the optic nerve. It plays an essential role in recognizing faces, reading, identifying colors, and seeing objects clearly.

When medication-related damage affects retinal cells, these functions may become impaired. This is why eye monitoring is an important part of long-term treatment.

Why Does Hydroxychloroquine Need Regular Eye Exams?

The main reason for regular eye examinations is the possibility of retinal toxicity. This occurs when the medication affects sensitive cells within the retina, particularly those responsible for detailed central vision.

Unlike some medication side effects, retinal damage may develop without obvious warning signs. A person might feel perfectly comfortable and continue performing everyday activities while early changes are already developing.

An eye examination allows an ophthalmologist to look for abnormalities that cannot easily be detected through ordinary vision checks.

Detecting Retinal Damage Before Symptoms Appear

One of the most important purposes of screening is identifying retinal changes before they affect noticeable vision.

Early retinal damage may not cause pain, redness, irritation, or blurred vision. Patients may therefore have no reason to suspect a problem.

Specialized eye tests can reveal subtle changes in retinal structure and function. Detecting these abnormalities early gives patients and their healthcare providers an opportunity to discuss treatment options before the condition becomes severe.

Preventing Permanent Vision Problems

Retinal toxicity caused by the medication can be irreversible, particularly when damage becomes advanced.

Once retinal cells are significantly damaged, stopping the medication may not restore normal vision. In some cases, the condition can continue progressing even after treatment has ended.

Regular screening helps identify possible toxicity at an earlier stage, when the risk of serious visual consequences may be reduced.

Monitoring Changes Over Time

A single eye examination provides information about the condition of the retina at one particular moment. However, comparing examinations from different years can provide a much clearer picture.

Ophthalmologists can compare current imaging with earlier results to identify changes in retinal thickness, structure, and function.

This comparison is especially valuable for people who have taken the medication for several years.

What Is Hydroxychloroquine Retinopathy?

Hydroxychloroquine retinopathy is a condition in which the medication causes damage to the retina. It is an uncommon but potentially serious complication associated with prolonged exposure or excessive daily dosing.

The retina contains specialized cells called photoreceptors. These cells respond to light and help the brain interpret visual information. When retinal toxicity develops, these structures may gradually become thinner or damaged.

The condition often affects the macula, the central area of the retina responsible for sharp vision. Damage in this region can interfere with activities that require detailed eyesight.

How Does Retinal Toxicity Develop?

The exact biological process is complex. Research suggests that the medication can accumulate within retinal tissues and interfere with normal cellular functions.

Over time, this may affect the photoreceptors and supporting retinal cells. Structural changes can develop gradually, even when the patient does not experience noticeable visual symptoms.

The likelihood of toxicity depends on several factors, including:

• Daily medication dosage.

• Total duration of treatment.

• Kidney function.

• Other medications being taken.

• Existing retinal conditions.

• Age when treatment begins.

It is important to understand that taking the medication does not automatically mean someone will develop eye damage. Many patients use it for years without experiencing retinal toxicity, especially when appropriate dosing and screening recommendations are followed.

Why Is Early Detection So Important?

Early retinal changes may be difficult to notice without specialized equipment.

As toxicity progresses, patients may experience difficulty reading, recognizing faces, or seeing objects clearly. Some may develop missing areas in their central or surrounding vision.

Unfortunately, advanced retinal damage can be permanent. This makes early screening especially important for people receiving long-term treatment.

Who Is at Greater Risk of Eye Damage?

Not everyone taking this medication has the same risk of developing retinal toxicity. Certain health conditions and treatment-related factors can increase the likelihood of complications.

Understanding these risk factors helps doctors determine when screening should begin and whether additional monitoring is necessary.

High Daily Dosage

The amount of medication taken each day is one of the most important risk factors.

According to the American Academy of Ophthalmology's revised 2025 recommendations, the recommended maximum daily dosage for routine risk management is 5 milligrams per kilogram of actual body weight.

Taking more than the recommended amount can increase the likelihood of retinal toxicity.

However, patients should never calculate or change their dosage independently. The prescribing doctor must consider the patient's condition, weight, treatment response, and other medical circumstances.

Long-Term Medication Use

The risk of retinal toxicity generally increases with the number of years a person takes the medication.

Although serious damage is uncommon during the first few years when the recommended dosage is followed, the possibility becomes more important with prolonged exposure.

This is why patients who continue treatment for five years or longer need particular attention to regular screening.

Kidney Disease

The kidneys help remove the medication from the body. When kidney function is reduced, the drug may remain in the body at higher levels.

This can increase exposure of retinal tissues and raise the possibility of toxicity.

Patients with kidney disease may need dosage adjustments and earlier or more frequent eye examinations.

Taking Certain Other Medications

Some medications may increase the risk of retinal complications when used alongside this treatment.

For example, tamoxifen use is recognized as an additional risk factor in current ophthalmology recommendations.

Patients should inform their prescribing doctor and eye specialist about all prescription medicines, over-the-counter products, and supplements they use.

Older Age at Treatment Initiation

Beginning treatment at an older age is another recognized risk factor.

Age-related retinal conditions can also make it more difficult to distinguish medication-related damage from other eye problems. This makes a detailed baseline examination particularly valuable.

When Should Patients Have Their First Eye Examination?

The timing of the first eye examination is important because it establishes a reference point for future monitoring.

The American Academy of Ophthalmology's 2025 revised recommendations advise obtaining a baseline examination soon after treatment begins.

This examination helps the ophthalmologist identify existing retinal abnormalities and document the condition of the eyes before long-term exposure.

Baseline Screening

A baseline examination should generally include:

• A comprehensive eye examination.

• Optical coherence tomography (OCT).

• Wide-pattern fundus autofluorescence (FAF).

These tests help establish whether the retina is healthy and provide images that can be compared with future examinations.

A baseline assessment is particularly useful when patients already have retinal conditions that could resemble medication-related damage.

Annual Eye Examinations

Annual screening is recommended during continued treatment.

However, patients without significant risk factors may be able to defer annual toxicity screening until after the first five years of medication use, provided a reliable monitoring plan is in place.

People with important risk factors, such as kidney disease or excessive daily dosing, should generally begin annual screening from the start of treatment.

The appropriate schedule should be determined by the ophthalmologist and prescribing doctor.

What Tests Are Performed During a Hydroxychloroquine Eye Examination?

Eye examinations for medication-related retinal toxicity involve more than checking whether someone can read letters on an eye chart.

Specialized imaging and functional tests help doctors identify subtle abnormalities in the retina.

Optical Coherence Tomography (OCT)

Optical coherence tomography is one of the most important screening tools for detecting retinal toxicity.

It uses light waves to create detailed cross-sectional images of the retina. These images allow the ophthalmologist to examine different retinal layers and identify changes that may not be visible during a routine eye examination.

OCT can reveal:

• Thinning of retinal layers.

• Changes in photoreceptor structures.

• Abnormalities around the macula.

• Early signs of medication-related damage.

Comparing OCT images from different appointments helps doctors identify whether retinal structures are changing over time.

Fundus Autofluorescence (FAF)

Fundus autofluorescence is another important imaging technique used in screening.

It examines naturally occurring fluorescent substances within the retina, particularly in the retinal pigment epithelium.

Changes in autofluorescence patterns can provide information about retinal health and help identify areas that may be affected by medication toxicity.

The 2025 ophthalmology recommendations support wide-pattern FAF alongside OCT as a primary screening method.

Visual Field Testing

Visual field testing evaluates how well a person can see objects in different areas of their visual field.

During the examination, patients look at a central point while responding whenever they notice small flashes of light in different locations.

This test can help identify missing or reduced areas of vision that may indicate retinal problems.

Visual field testing is useful as a supporting or confirmatory examination. However, current recommendations do not consider it the primary screening method because results can vary depending on patient concentration and testing reliability.

Multifocal Electroretinography

Multifocal electroretinography, commonly called mfERG, measures electrical responses from different regions of the retina.

It helps ophthalmologists assess whether retinal cells are functioning normally.

This examination may be recommended when OCT, autofluorescence, or visual field findings are unclear.

It is not routinely necessary for every patient, but it can provide additional information when doctors suspect early retinal toxicity.

What Symptoms May Indicate Retinal Damage?

One challenge with medication-related retinal toxicity is that early changes often develop without noticeable symptoms.

Nevertheless, patients should understand the possible warning signs and report new visual problems to their healthcare providers.

Potential symptoms include:

• Blurred central vision.

• Difficulty reading small text.

• Problems recognizing familiar faces.

• Distorted straight lines.

• Missing areas in the visual field.

• Difficulty seeing details.

• Changes in color perception.

These symptoms do not necessarily mean that the medication has damaged the retina. Other eye conditions can cause similar problems.

However, new or worsening visual changes should be assessed promptly rather than waiting for the next scheduled screening appointment.

Sudden vision loss, a sudden shower of floaters, flashes of light, or a curtain-like shadow across the vision requires urgent eye assessment because these symptoms may indicate other serious eye conditions.

Can Eye Damage Be Reversed After Stopping Hydroxychloroquine?

The possibility of recovery depends on how much retinal damage has occurred.

In the earliest stages, identifying toxicity and discussing treatment changes may help prevent significant additional damage.

However, established retinal injury is generally not reversible. Patients with advanced toxicity may continue experiencing visual deterioration even after the medication has been discontinued.

This is particularly concerning when damage has extended to the retinal pigment epithelium, a layer that supports the function of photoreceptor cells.

For this reason, regular eye examinations are not simply routine medical appointments. They are an important opportunity to identify changes before extensive retinal injury develops.

Doctors must carefully balance the potential risks of continued treatment against the benefits of controlling the underlying disease.

Patients should never stop taking their medication without consulting the prescribing healthcare professional.

How Can Patients Protect Their Eyes During Treatment?

Although retinal toxicity is a potential concern, patients can take several practical steps to reduce risks and maintain good eye health.

The most effective approach combines appropriate medication management, regular screening, and communication between healthcare professionals.

Follow the Prescribed Dosage

Patients should take the medication exactly as prescribed.

Taking extra doses or changing the schedule without medical advice may increase the risk of unwanted effects.

Doctors should periodically review the prescribed dosage, particularly if a patient's body weight changes significantly or kidney function becomes impaired.

Never Miss Scheduled Eye Examinations

Keeping regular appointments is one of the most important ways to protect long-term vision.

Even when eyesight seems completely normal, screening may identify changes that are not yet noticeable.

Patients should keep copies of previous examination reports and imaging results whenever possible. These records help ophthalmologists compare retinal changes over time.

Inform Doctors About Medical Changes

Patients should tell their healthcare providers about new medical conditions, particularly kidney problems and changes in other medications.

These details may affect how frequently eye examinations are needed.

Communication between the prescribing physician and ophthalmologist also helps ensure that potential retinal problems are evaluated appropriately.

Report Unusual Vision Changes

Patients should not ignore changes in reading ability, central vision, or visual clarity.

Reporting symptoms early allows doctors to investigate whether they are related to medication toxicity or another eye condition.

What Happens If an Eye Examination Shows Possible Toxicity?

An abnormal screening result does not automatically mean that a patient must permanently discontinue treatment.

Some retinal abnormalities may be caused by other eye conditions, and certain screening findings require confirmation.

The ophthalmologist may recommend repeating an examination, obtaining additional imaging, or performing visual field testing.

If the results strongly suggest medication-related toxicity, the ophthalmologist should communicate with the prescribing physician.

Together, they can discuss the available options.

Depending on the severity of the findings and the importance of treatment, these options may include:

• Reviewing and adjusting the prescribed dosage.

• Discontinuing the medication under medical supervision.

• Considering alternative treatments for the underlying condition.

• Increasing the frequency of retinal monitoring.

• Referring the patient to a retinal specialist.

The decision should consider both eye health and the consequences of poorly controlled autoimmune disease.

For example, stopping an effective medication without arranging an alternative treatment could allow the original condition to become active again.

Therefore, decisions should always involve the appropriate healthcare professionals.

Common Myths About Hydroxychloroquine and Eye Examinations

Several misconceptions can cause patients to underestimate the importance of regular screening.

Understanding the facts helps people make better decisions about their treatment.

Myth 1: Eye Examinations Are Only Necessary When Vision Becomes Blurry

Fact: Early retinal toxicity may develop without noticeable symptoms. Specialized examinations can identify changes before a patient experiences visual problems.

Myth 2: Everyone Taking the Medication Will Develop Eye Damage

Fact: Retinal toxicity does not affect every patient. Risk depends on dosage, treatment duration, kidney function, and other individual factors.

Myth 3: A Normal Eye Examination Means Future Examinations Are Unnecessary

Fact: A normal examination provides reassurance about the current condition of the retina, but it does not guarantee that future toxicity will never develop.

Continued monitoring remains important during long-term treatment.

Myth 4: Stopping Treatment Always Restores Vision

Fact: Early identification and discontinuation may reduce the likelihood of further damage, but established retinal injury is generally irreversible. Advanced toxicity may continue progressing after treatment ends.

Questions Patients Should Ask Their Eye Specialist

Patients can make their appointments more productive by discussing their treatment history and individual risk factors.

Useful questions include:

1. Is my current retinal examination normal?

2. How often should I have screening examinations?

3. Do my dosage and body weight increase my risk?

4. Which imaging tests are appropriate for my situation?

5. Are there any existing eye conditions that could affect my screening results?

6. What symptoms should I report immediately?

7. Should my prescribing doctor review my medication dosage?

These questions help patients understand their screening schedule and make informed decisions about long-term treatment.

Conclusion

Eye examinations are an essential part of long-term treatment monitoring for people taking hydroxychloroquine. Although the medication provides valuable benefits for patients with autoimmune and inflammatory conditions, it can sometimes cause retinal toxicity that may lead to permanent vision problems.

The main reason regular screening is necessary is that retinal damage can develop gradually without producing noticeable symptoms during its early stages. Specialized examinations allow ophthalmologists to identify subtle abnormalities before they become severe.

Optical coherence tomography and fundus autofluorescence are particularly important screening methods under the American Academy of Ophthalmology's revised recommendations. Visual field testing and multifocal electroretinography may provide additional information when necessary.

Patients should also understand the factors that influence retinal toxicity, including daily dosage, treatment duration, kidney function, tamoxifen use, and age when treatment begins. Following the prescribed dosage and maintaining regular appointments can help reduce the possibility of serious complications.

A baseline eye examination soon after starting treatment establishes an important reference point. Annual screening is recommended during continued use, although patients without significant risk factors may defer annual toxicity screening during the first five years under appropriate medical guidance.

Most importantly, patients should not wait until their vision becomes blurry before seeking an eye examination. Early detection provides a better opportunity to manage potential complications and protect remaining vision.

With appropriate medical supervision, responsible medication use, and consistent eye monitoring, many patients can continue benefiting from treatment while keeping the risk of serious retinal damage low. Regular communication between the ophthalmologist and prescribing doctor remains one of the most effective ways to balance treatment benefits with long-term eye safety.